Literature DB >> 26323387

Breast cancer: The debate over post-mastectomy radiotherapy should continue.

Caspian Oliai1, Sara A Hurvitz1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26323387     DOI： 10.1038/nrclinonc.2015.147

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  12 in total

Review 1.  Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype.

Authors:  Aoife J Lowery; Malcolm R Kell; Ronan W Glynn; Michael J Kerin; Karl J Sweeney
Journal:  Breast Cancer Res Treat       Date:  2011-12-07       Impact factor: 4.872

2.  The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy.

Authors:  Ryan M Lanning; Monica Morrow; Nadeem Riaz; Heather L McArthur; Chau Dang; Tracy-Ann Moo; Mahmoud El-Tamer; Kate Krause; Chun Siu; Meier Hsu; Zhigang Zhang; Xin Pei; Beryl McCormick; Simon N Powell; Alice Ho
Journal:  Ann Surg Oncol       Date:  2015-01-07       Impact factor: 5.344

3.  Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

Authors:  Edith A Perez; Edward H Romond; Vera J Suman; Jong-Hyeon Jeong; George Sledge; Charles E Geyer; Silvana Martino; Priya Rastogi; Julie Gralow; Sandra M Swain; Eric P Winer; Gerardo Colon-Otero; Nancy E Davidson; Eleftherios Mamounas; Jo Anne Zujewski; Norman Wolmark
Journal:  J Clin Oncol       Date:  2014-10-20       Impact factor: 44.544

4.  Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

Authors:  Philip M Poortmans; Sandra Collette; Carine Kirkove; Erik Van Limbergen; Volker Budach; Henk Struikmans; Laurence Collette; Alain Fourquet; Philippe Maingon; Mariacarla Valli; Karin De Winter; Simone Marnitz; Isabelle Barillot; Luciano Scandolaro; Ernest Vonk; Carla Rodenhuis; Hugo Marsiglia; Nicola Weidner; Geertjan van Tienhoven; Christoph Glanzmann; Abraham Kuten; Rodrigo Arriagada; Harry Bartelink; Walter Van den Bogaert
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

5.  Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.

Authors:  Eleftherios P Mamounas; Stewart J Anderson; James J Dignam; Harry D Bear; Thomas B Julian; Charles E Geyer; Alphonse Taghian; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

Authors:  Marianne Kyndi; Flemming B Sørensen; Helle Knudsen; Marie Overgaard; Hanne Melgaard Nielsen; Jens Overgaard
Journal:  J Clin Oncol       Date:  2008-02-19       Impact factor: 44.544

8.  Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.

Authors:  Andrew McBride; Pamela Allen; Wendy Woodward; Michelle Kim; Henry M Kuerer; Eva Katherine Drinka; Aysegul Sahin; Eric A Strom; Aman Buzdar; Vicente Valero; Gabriel N Hortobagyi; Kelly K Hunt; Thomas A Buchholz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-07       Impact factor: 7.038

9.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors:  R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal:  Lancet       Date:  2011-12-05       Impact factor: 79.321

10.  Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen.

Authors:  Mitch Dowsett; Jack Cuzick; Jim Ingle; Alan Coates; John Forbes; Judith Bliss; Marc Buyse; Michael Baum; Aman Buzdar; Marco Colleoni; Charles Coombes; Claire Snowdon; Michael Gnant; Raimund Jakesz; Manfred Kaufmann; Francesco Boccardo; Jon Godwin; Christina Davies; Richard Peto
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544
View more
  1 in total

1.  Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes.

Authors:  Ning Zhang; Jiashu Zhang; Hanwen Zhang; Ying Liu; Wenjing Zhao; Lijuan Wang; Bing Chen; Meena S Moran; Bruce G Haffty; Qifeng Yang
Journal:  Oncologist       Date:  2019-07-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.